// Auto-generated - do not edit
export const substanceName = "SAM-e";
export const sources = [{"id":"drugbank","fileName":"DRUGBANK - SAM-e.md","displayName":"DrugBank","size":19952},{"id":"protestkit","fileName":"PROTESTKIT - SAM-e.json","displayName":"Protest Kit","size":2548},{"id":"psychonautwiki","fileName":"PSYCHONAUTWIKI - SAM-e.md","displayName":"PsychonautWiki","size":14843},{"id":"wikipedia","fileName":"WIKIPEDIA - SAM-e.md","displayName":"Wikipedia","size":10300}];
export const contents: Record<string, string> = {
  "drugbank": `# Ademetionine
*Source: https://go.drugbank.com/drugs/DB00118*

## Overview

### Description

This compound belongs to the class of organic compounds known as 5'-deoxy-5'-thionucleosides. These are 5'-deoxyribonucleosides  in which the ribose is thio-substituted at the 5'position by a S-alkyl group.

### Background

Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed)

### Indication

S-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as a dietary supplement for the support of bone and joint health, as well as mood and emotional well being.

### Pharmacodynamics

S-adenosylmethionine is an intermediate metabolite of methionine. Its involvement in methylation assists in cellular growth and repair, maintains the phospho-bilipid layer in cell membranes. It also helps in the maintenance of the action of several hormones and neurotransmitters that affect mood. Highest concentration are found in the brain and the liver.

### Absorption

S-Adenosylmethionine is absorbed from the small intestine following oral intake. As absorption is affected by food, it is best to take on an empty stomach. Bioavailability is low following oral intake.

### Metabolism

Significant first-pass metabolism in the liver. Approximately 50% of S-Adenosylmethionine (SAMe) is metabolized in the liver. SAMe is metabolized to S-adenosylhomocysteine, which is then metabolized to homocysteine. Homocysteine can either be metabolized to cystathionine and then cysteine or to methionine. The cofactor in the metabolism of homocysteine to cysteine is vitamin B6. Cofactors for the metabolism of homocysteine to methionine are folic acid, vitamin B12 and betaine.
Hover over products below to view reaction partners
Ademetionine
Cystathionine
Cysteine
Methionine
Homocysteine
S-Adenosylhomocysteine

### Toxicity

Irritating to mucus membranes and upper respiratory tract. Can cause CNS depression.

### Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Acetaminophen
Ademetionine may increase the hepatotoxic activities of Acetaminophen.
Aminophylline
The metabolism of Aminophylline can be decreased when combined with Ademetionine.
Benzocaine
The metabolism of Benzocaine can be decreased when combined with Ademetionine.
Benzyl alcohol
The metabolism of Benzyl alcohol can be decreased when combined with Ademetionine.
Carvedilol
The metabolism of Carvedilol can be decreased when combined with Ademetionine.

## Chemical Information

**DrugBank ID:** DB00118

**Synonyms:** Ademetionine
AdoMet
L-S-Adenosylmethionine
S-Adenosylmethionine
SAM
SAM-e
SAMe

**Chemical Formula:** C
15
H
22
N
6
O
5
S

**SMILES:** C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N

**Weight:** Average: 398.44
Monoisotopic: 398.137239006

**IUPAC Name:** (2S)-2-amino-4-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(methyl)sulfaniumyl)butanoate

## Additional Information

### Modality

Small Molecule

### Patents

0

### Indicated Conditions

6

### Phase 0

0

### Phase 1

1

### Phase 2

1

### Phase 3

5

### Phase 4

5

### Generic Name

Ademetionine

### DrugBank Accession Number

DB00118

### Groups

Approved, Investigational, Nutraceutical

### Structure

3D
Download
MOL
SDF
3D-SDF
PDB
SMILES
InChI
Similar Structures
Structure for Ademetionine (DB00118)
×
Close

### Associated Conditions

Indication Type
Indication
Combined Product Details
Approval Level
Age Group
Patient Characteristics
Dose Form
Treatment of
Fatigue
••••••••••••
Create Account
••••••• ••••••
Treatment of
Intrahepatic cholestasis
••••••••••••
Create Account
•••••
•••••••••
••••••• ••••••• •••••••
Treatment of
Intrahepatic cholestasis
••••••••••••
Create Account
•••••
••••••• ••••••• •••••••
Treatment of
Intrahepatic cholestasis
••••••••••••
Create Account
•••••
••••••••••••• •••••
••••••• ••••••• •••••••
Treatment of
Intrahepatic cholestasis
••••••••••••
Create Account
••••••• ••••••
Create Account

### Mechanism of action

S-Adenosylmethionine (SAMe) is a natural substance present in the cells of the body. It is a direct metabolite of the essential amino acid L-methionine. SAMe plays a crucial biochemical role in the body by donating a one-carbon methyl group in a process called transmethylation. SAMe, formed from the reaction of L-methionine and adenosine triphosphate catalyzed by the enzyme S-adenosylmethionine synthetase, is the methyl-group donor in the biosynthesis of both DNA and RNA nucleic acids, phospholipids, proteins, epinephrine, melatonin, creatine and other molecules.
Target
Actions
Organism
U
Catechol O-methyltransferase
cofactor
Humans
U
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1
Not Available
Humans
U
Arsenite methyltransferase
Not Available
Humans
U
Glycine N-methyltransferase
cofactor
Humans
U
S-adenosylmethionine decarboxylase proenzyme
cofactor
Humans
U
S-adenosylmethionine synthase isoform type-2
cofactor
Humans
U
Cystathionine beta-synthase
activator
Humans
U
S-adenosylmethionine synthase isoform type-1
cofactor
Humans

### Product Ingredients

Ingredient
UNII
CAS
InChI Key
Ademetionine butanedisulfonate
C5BTS0548U
200393-05-1
TYXBLACMHQBEEW-XKGORWRGSA-N
Ademetionine disulfate ditosylate
Not Available
Not Available
Not applicable
Ademetionine disulfate monotosylate
Not Available
Not Available
Not applicable
Ademetionine disulfate tosylate
564ROC9U09
97540-22-2
XDCFCHNAIMYBAZ-XQVUROGGSA-N
Ademetionine tosylate
Not Available
Not Available
Not applicable

### International/Other Brands

Donamet
/
Sam-Sulfate (Natrol)
/
SAMe
/
SAMe Rx-Mood (Nature's Plus)

### Over the Counter Products

Name
Dosage
Strength
Route
Labeller
Marketing Start
Marketing End
Region
Image
Heptral 500mg Gastroresistant Tablets
Tablet
500 mg
Oral
ABBOTT LABORATORIES (M) SDN. BHD.
2020-09-08
Not applicable
Malaysia

### Mixture Products

Name
Ingredients
Dosage
Route
Labeller
Marketing Start
Marketing End
Region
Image
HEPASELAMİN AMİNOASİT IV İNFÜZYON ÇÖZELTİSİ 500 ML SETLİ ŞİŞE
Ademetionine
(0.24 %)
+
Adenine
(0.8 %)
+
Ascorbic acid
(0.6 %)
+
Aspartame
(0.9 %)
+
Biotin
(0.1 %)
+
Calcifediol
(0.9 %)
+
Cysteine
(0.066 %)
+
Lysine
(0.61 %)
+
Methionine
(0.5 %)
+
NADH
(0.45 %)
+
Phosphoric acid
(0.115 %)
+
Thiamine
(0.02 %)
+
Tryptophan
(1.1 %)
+
Tyrosine
(0.1 %)
+
Valine
(0.77 %)
+
Vitamin A
(0.84 %)
Solution
Intravenous
OSEL İLAÇ SAN. VE TİC. A.Ş.
2003-12-31
Not applicable
Turkey
HEPASELAMİN AMİNOASİT IV İNFÜZYON ÇÖZELTİSİ 500 ML SETSİZ ŞİŞE
Ademetionine
(0.24 %)
+
Adenine
(0.8 %)
+
Ascorbic acid
(0.6 %)
+
Aspartame
(0.9 %)
+
Biotin
(0.1 %)
+
Calcifediol
(0.9 %)
+
Cysteine
(0.066 %)
+
Lysine
(0.61 %)
+
Methionine
(0.5 %)
+
NADH
(0.45 %)
+
Phosphoric acid
(0.115 %)
+
Thiamine
(0.02 %)
+
Tryptophan
(1.1 %)
+
Tyrosine
(0.1 %)
+
Valine
(0.77 %)
+
Vitamin A
(0.84 %)
Solution
Intravenous
OSEL İLAÇ SAN. VE TİC. A.Ş.
2003-12-31
Not applicable
Turkey
HEPATAMINE %8 500 ML(SETLI)
Ademetionine
(0.24 %)
+
Adenine
(0.8 %)
+
Ascorbic acid
(0.6 %)
+
Aspartame
(0.9 %)
+
Biotin
(0.1 %)
+
Calcifediol
(0.9 %)
+
Cysteine
(0.066 %)
+
Lysine
(0.61 %)
+
Methionine
(0.5 %)
+
NADH
(0.45 %)
+
Phosphoric acid
(0.115 %)
+
Sodium bisulfite
(0.01 %)
+
Thiamine
(0.02 %)
+
Tryptophan
(1.1 %)
+
Tyrosine
(0.1 %)
+
Valine
(0.77 %)
+
Vitamin A
(0.84 %)
Solution
Intravenous
ECZACIBAŞI-BAXTER HASTANE ÜRÜNLERİ SAN.VE TİC. A.Ş.
1990-01-16
2024-01-23
Turkey
HEPATAMINE %8 500 ML(SETSIZ)
Ademetionine
(0.24 %)
+
Adenine
(0.8 %)
+
Ascorbic acid
(0.6 %)
+
Aspartame
(0.9 %)
+
Biotin
(0.1 %)
+
Calcifediol
(0.9 %)
+
Cysteine
(0.066 %)
+
Lysine
(0.61 %)
+
Methionine
(0.5 %)
+
NADH
(0.45 %)
+
Phosphoric acid
(0.115 %)
+
Sodium bisulfite
(0.01 %)
+
Thiamine
(0.02 %)
+
Tryptophan
(1.1 %)
+
Tyrosine
(0.1 %)
+
Valine
(0.77 %)
+
Vitamin A
(0.84 %)
Solution
Intravenous
ECZACIBAŞI-BAXTER HASTANE ÜRÜNLERİ SAN.VE TİC. A.Ş.
1990-01-16
2024-01-23
Turkey

### ATC Codes

A16AA02 — Ademetionine
A16AA — Amino acids and derivatives
A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A — ALIMENTARY TRACT AND METABOLISM

### Drug Categories

Alimentary Tract and Metabolism
Amino Acids
Amino Acids and Derivatives
Amino Acids, Peptides, and Proteins
Amino Acids, Sulfur
Cytochrome P-450 CYP2E1 Inhibitors
Cytochrome P-450 CYP2E1 Inhibitors (weak)
Cytochrome P-450 Enzyme Inhibitors
Dietary Supplements
Heterocyclic Compounds, Fused-Ring
Nucleic Acids, Nucleotides, and Nucleosides
Nucleosides
Purine Nucleosides
Purines
Ribonucleosides
Sulfur Compounds
Supplements

### Chemical TaxonomyProvided byClassyfire

Description
This compound belongs to the class of organic compounds known as 5'-deoxy-5'-thionucleosides. These are 5'-deoxyribonucleosides  in which the ribose is thio-substituted at the 5'position by a S-alkyl group.
Kingdom
Organic compounds
Super Class
Nucleosides, nucleotides, and analogues
Class
5'-deoxyribonucleosides
Sub Class
5'-deoxy-5'-thionucleosides
Direct Parent
5'-deoxy-5'-thionucleosides
Alternative Parents
Methionine and derivatives
/
Glycosylamines
/
Pentoses
/
6-aminopurines
/
L-alpha-amino acids
/
Thia fatty acids
/
Aminopyrimidines and derivatives
/
Hydroxy fatty acids
/
N-substituted imidazoles
/
Imidolactams
/
Tetrahydrofurans
/
Heteroaromatic compounds
/
Secondary alcohols
/
1,2-diols
/
Amino acids
/
Carboxylic acid salts
/
Oxacyclic compounds
/
Azacyclic compounds
/
Carboxylic acids
/
Monocarboxylic acids and derivatives
/
Organopnictogen compounds
/
Organic salts
/
Carbonyl compounds
/
Organosulfur compounds
/
Organic oxides
/
Organic zwitterions
/
Hydrocarbon derivatives
/
Monoalkylamines
show 18 more
Substituents
1,2-diol
/
5'-deoxy-5'-thionucleoside
/
6-aminopurine
/
Alcohol
/
Alpha-amino acid
/
Alpha-amino acid or derivatives
/
Amine
/
Amino acid
/
Amino acid or derivatives
/
Aminopyrimidine
/
Aromatic heteropolycyclic compound
/
Azacycle
/
Azole
/
Carbonyl group
/
Carboxylic acid
/
Carboxylic acid derivative
/
Carboxylic acid salt
/
Fatty acyl
/
Glycosyl compound
/
Heteroaromatic compound
/
Hydrocarbon derivative
/
Hydroxy fatty acid
/
Imidazole
/
Imidazopyrimidine
/
Imidolactam
/
L-alpha-amino acid
/
Methionine or derivatives
/
Monocarboxylic acid or derivatives
/
Monosaccharide
/
N-glycosyl compound
/
N-substituted imidazole
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organic salt
/
Organic zwitterion
/
Organoheterocyclic compound
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Organosulfur compound
/
Oxacycle
/
Pentose monosaccharide
/
Primary aliphatic amine
/
Primary amine
/
Purine
/
Pyrimidine
/
Secondary alcohol
/
Tetrahydrofuran
/
Thia fatty acid
show 40 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
sulfonium betaine (
CHEBI:67040
)
/
Coenzymes (
C00019
)

### Kingdom

Organic compounds

### Super Class

Nucleosides, nucleotides, and analogues

### Class

5'-deoxyribonucleosides

### Sub Class

5'-deoxy-5'-thionucleosides

### Direct Parent

5'-deoxy-5'-thionucleosides

### Alternative Parents

Methionine and derivatives
/
Glycosylamines
/
Pentoses
/
6-aminopurines
/
L-alpha-amino acids
/
Thia fatty acids
/
Aminopyrimidines and derivatives
/
Hydroxy fatty acids
/
N-substituted imidazoles
/
Imidolactams
/
Tetrahydrofurans
/
Heteroaromatic compounds
/
Secondary alcohols
/
1,2-diols
/
Amino acids
/
Carboxylic acid salts
/
Oxacyclic compounds
/
Azacyclic compounds
/
Carboxylic acids
/
Monocarboxylic acids and derivatives
/
Organopnictogen compounds
/
Organic salts
/
Carbonyl compounds
/
Organosulfur compounds
/
Organic oxides
/
Organic zwitterions
/
Hydrocarbon derivatives
/
Monoalkylamines
show 18 more

### Substituents

1,2-diol
/
5'-deoxy-5'-thionucleoside
/
6-aminopurine
/
Alcohol
/
Alpha-amino acid
/
Alpha-amino acid or derivatives
/
Amine
/
Amino acid
/
Amino acid or derivatives
/
Aminopyrimidine
/
Aromatic heteropolycyclic compound
/
Azacycle
/
Azole
/
Carbonyl group
/
Carboxylic acid
/
Carboxylic acid derivative
/
Carboxylic acid salt
/
Fatty acyl
/
Glycosyl compound
/
Heteroaromatic compound
/
Hydrocarbon derivative
/
Hydroxy fatty acid
/
Imidazole
/
Imidazopyrimidine
/
Imidolactam
/
L-alpha-amino acid
/
Methionine or derivatives
/
Monocarboxylic acid or derivatives
/
Monosaccharide
/
N-glycosyl compound
/
N-substituted imidazole
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organic salt
/
Organic zwitterion
/
Organoheterocyclic compound
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Organosulfur compound
/
Oxacycle
/
Pentose monosaccharide
/
Primary aliphatic amine
/
Primary amine
/
Purine
/
Pyrimidine
/
Secondary alcohol
/
Tetrahydrofuran
/
Thia fatty acid
show 40 more

### Molecular Framework

Aromatic heteropolycyclic compounds

### External Descriptors

sulfonium betaine (
CHEBI:67040
)
/
Coenzymes (
C00019
)

### Affected organisms

Humans and other mammals

### UNII

7LP2MPO46S

### CAS number

29908-03-0

### InChI Key

MEFKEPWMEQBLKI-AIRLBKTGSA-N

### InChI

InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1

### Synthesis Reference

Takayasu Tsuchida, Fumihiro Yoshinaga, Shinji Okumura, "Method for producing S-adenosylmethionine or methylthioadenosine by yeast." U.S. Patent US3962034, issued November, 1971.
US3962034

### General References

Finkelstein JD, Martin JJ: Homocysteine. Int J Biochem Cell Biol. 2000 Apr;32(4):385-9. [
Article
]
Fodinger M, Horl WH, Sunder-Plassmann G: Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol. 2000 Jan-Feb;13(1):20-33. [
Article
]
Roje S: S-Adenosyl-L-methionine: beyond the universal methyl group donor. Phytochemistry. 2006 Aug;67(15):1686-98. [
Article
]
Loenen WA: S-adenosylmethionine: jack of all trades and master of everything? Biochem Soc Trans. 2006 Apr;34(Pt 2):330-3. [
Article
]
Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, McCann PP: S-Adenosylmethionine and methylation. FASEB J. 1996 Mar;10(4):471-80. [
Article
]

### External Links

Human Metabolome Database
HMDB0062709
KEGG Compound
C00019
PubChem Compound
34755
PubChem Substance
46505280
ChemSpider
31982
BindingDB
28422
RxNav
9504
ChEBI
67040
ChEMBL
CHEMBL1088977
PharmGKB
PA164754994
PDBe Ligand
SAM
Drugs.com
Drugs.com Drug Page
PDRhealth
PDRhealth Drug Page
Wikipedia
S-Adenosyl_methionine

### Human Metabolome Database

HMDB0062709

### KEGG Compound

C00019

### PubChem Compound

34755

### PubChem Substance

46505280

### ChemSpider

31982

### BindingDB

28422

### RxNav

9504

### ChEBI

67040

### ChEMBL

CHEMBL1088977

### PharmGKB

PA164754994

### PDBe Ligand

SAM

### Drugs.com

Drugs.com Drug Page

### PDRhealth

PDRhealth Drug Page

### Wikipedia

S-Adenosyl_methionine

### MSDS

Download
(35.5 KB)

### Packagers

CVS Pharmacy
Pharmavite

### Dosage Forms

Form
Route
Strength
Tablet, delayed release
Oral
300 MG
Tablet, delayed release
Oral
500 MG
Tablet
Oral
Solution
Intravenous
Injection, powder, for solution
Intramuscular; Intravenous
100 MG/5ML
Injection, powder, for solution
Intramuscular; Intravenous
200 MG/5ML
Injection, powder, for solution
Intramuscular; Intravenous
400 MG/5ML
Tablet, delayed release
Oral
200 MG
Tablet, delayed release
Oral
400 MG
Injection, powder, for solution
Intramuscular; Intravenous
300 MG/5ML
Injection, powder, for solution
Intramuscular; Intravenous
500 MG/5ML
Tablet
Oral
300 MG
Tablet
Oral
500 MG

### Prices

Unit description
Cost
Unit
Sam-e 400 mg tablet
0.86USD
tablet
CVS Pharmacy sam-e 400 mg tablet
0.79USD
tablet
Sam-e 200 mg tablet
0.59USD
tablet
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.

### State

Solid

### Experimental Properties

Property
Value
Source
boiling point (°C)
78 °C
Not Available

### Predicted Properties

Property
Value
Source
Water Solubility
1.62 mg/mL
ALOGPS
logP
0.05
ALOGPS
logP
-5.3
Chemaxon
logS
-2.4
ALOGPS
pKa (Strongest Acidic)
1.7
Chemaxon
pKa (Strongest Basic)
9.41
Chemaxon
Physiological Charge
1
Chemaxon
Hydrogen Acceptor Count
10
Chemaxon
Hydrogen Donor Count
4
Chemaxon
Polar Surface Area
185.46 Å
2
Chemaxon
Rotatable Bond Count
7
Chemaxon
Refractivity
107.07 m
3
·mol
-1
Chemaxon
Polarizability
39.26 Å
3
Chemaxon
Number of Rings
3
Chemaxon
Bioavailability
1
Chemaxon
Rule of Five
Yes
Chemaxon
Ghose Filter
No
Chemaxon
Veber's Rule
No
Chemaxon
MDDR-like Rule
Yes
Chemaxon

### Predicted ADMET Features

Property
Value
Probability
Human Intestinal Absorption
+
0.8102
Blood Brain Barrier
-
0.8894
Caco-2 permeable
-
0.7307
P-glycoprotein substrate
Substrate
0.7584
P-glycoprotein inhibitor I
Non-inhibitor
0.9664
P-glycoprotein inhibitor II
Non-inhibitor
0.993
Renal organic cation transporter
Non-inhibitor
0.9295
CYP450 2C9 substrate
Non-substrate
0.8308
CYP450 2D6 substrate
Non-substrate
0.8224
CYP450 3A4 substrate
Substrate
0.5753
CYP450 1A2 substrate
Non-inhibitor
0.8308
CYP450 2C9 inhibitor
Non-inhibitor
0.8396
CYP450 2D6 inhibitor
Non-inhibitor
0.9192
CYP450 2C19 inhibitor
Non-inhibitor
0.8457
CYP450 3A4 inhibitor
Non-inhibitor
0.9731
CYP450 inhibitory promiscuity
Low CYP Inhibitory Promiscuity
0.9647
Ames test
Non AMES toxic
0.6899
Carcinogenicity
Non-carcinogens
0.9417
Biodegradation
Not ready biodegradable
0.9486
Rat acute toxicity
2.5758 LD50, mol/kg
Not applicable
hERG inhibition (predictor I)
Weak inhibitor
0.9755
hERG inhibition (predictor II)
Non-inhibitor
0.7962
ADMET data is predicted using
admetSAR
, a free tool for evaluating chemical ADMET properties. (
23092397
)

### Spectra

Spectrum
Spectrum Type
Splash Key
Predicted GC-MS Spectrum - GC-MS
Predicted GC-MS
splash10-0a6r-5945000000-faee11753c0aa9b74806
Predicted 1H NMR Spectrum
1D NMR
Not Applicable
Predicted 13C NMR Spectrum
1D NMR
Not Applicable

### Chromatographic Properties

Collision Cross Sections (CCS)
Adduct
CCS Value (Å
2
)
Source type
Source
[M-H]-
205.3486255
predicted
DarkChem Lite v0.1.0
[M-H]-
203.0333255
predicted
DarkChem Lite v0.1.0
[M-H]-
181.81721
predicted
DeepCCS 1.0 (2019)
[M+H]+
204.3834255
predicted
DarkChem Lite v0.1.0
[M+H]+
200.4574255
predicted
DarkChem Lite v0.1.0
[M+H]+
183.88329
predicted
DeepCCS 1.0 (2019)
[M+Na]+
204.3789255
predicted
DarkChem Lite v0.1.0
[M+Na]+
202.2660255
predicted
DarkChem Lite v0.1.0
[M+Na]+
189.84372
predicted
DeepCCS 1.0 (2019)

### Kind

Protein

### Organism

Humans

### Pharmacological action

Unknown

### Actions

Inhibitor

### General Function

A cytochrome P450 monooxygenase involved in the metabolism of fatty acids (PubMed:10553002, PubMed:18577768). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:10553002, PubMed:18577768). Catalyzes the hydroxylation of carbon-hydrogen bonds. Hydroxylates fatty acids specifically at the omega-1 position displaying the highest catalytic activity for saturated fatty acids (PubMed:10553002, PubMed:18577768). May be involved in the oxidative metabolism of xenobiotics (Probable)

### Specific Function

4-nitrophenol 2-monooxygenase activity

### Gene Name

CYP2E1

### Uniprot ID

P05181

### Uniprot Name

Cytochrome P450 2E1

### Molecular Weight

56848.42 Da

### Curator comments

S-Adenosylmethionine is a substrate to the enzyme

`,
  "protestkit": `{
  "url": "https://psychonautwiki.org/wiki/SAM-e",
  "experiencesUrl": "https://www.reddit.com/search/?q=SAM-e",
  "name": "SAM-e",
  "aliases": [
    "methylguanidoacetic acid",
    "s-adenosyl methionine"
  ],
  "aliasesStr": "methylguanidoacetic acid,s-adenosyl methionine",
  "summary": null,
  "reagents": null,
  "classes": {
    "chemical": [
      "Nitrogenous organic acid"
    ],
    "psychoactive": [
      "Nootropic"
    ]
  },
  "toxicity": null,
  "addictionPotential": "not habit-forming with a low potential for abuse",
  "tolerance": null,
  "crossTolerances": null,
  "roas": [
    {
      "name": "Oral",
      "dosage": [
        {
          "name": "Threshold",
          "value": "200 mg"
        },
        {
          "name": "Light",
          "value": "400 - 800 mg"
        },
        {
          "name": "Common",
          "value": "800 - 1200 mg"
        },
        {
          "name": "Strong",
          "value": "1200 - 1600 mg"
        },
        {
          "name": "Heavy",
          "value": "1600 mg +"
        }
      ],
      "duration": [
        {
          "name": "Onset",
          "value": "1.67 - 3.0 hours"
        },
        {
          "name": "Total",
          "value": "8.0 - 12.0 hours"
        }
      ],
      "bioavailability": "2-10%"
    }
  ],
  "interactions": null,
  "effects": "Thought connectivity, Motivation enhancement, Memory enhancement, Dehydration, Headache, Stomach cramp, Rejuvenation, Analysis enhancement, Mindfulness, Cognitive euphoria, Irritability, Bodily control enhancement, Stimulation, Wakefulness, Appetite suppression, Pain relief, Anxiety suppression, Thought organization, Diarrhea, Mania, Muscle twitching, Focus intensification, Tactile intensification, Stamina intensification",
  "categorized_effects": {
    "Physical effects": [
      "Dehydration",
      "Headache",
      "Stomach cramp",
      "Bodily control enhancement",
      "Stimulation",
      "Appetite suppression",
      "Pain relief",
      "Diarrhea",
      "Muscle twitching",
      "Stamina intensification"
    ],
    "Mental effects": [
      "Thought connectivity",
      "Motivation enhancement",
      "Memory enhancement",
      "Rejuvenation",
      "Analysis enhancement",
      "Mindfulness",
      "Cognitive euphoria",
      "Irritability",
      "Wakefulness",
      "Anxiety suppression",
      "Thought organization",
      "Mania",
      "Focus intensification"
    ],
    "Sensory effects": [
      "Tactile intensification"
    ],
    "Uncategorized effects": []
  }
}`,
  "psychonautwiki": `# SAM-e
*Source: https://psychonautwiki.org/wiki/SAM-e*

## Dosage & Duration

### Oral

**Dosage:**
- Bioavailability: 2-10%
- Threshold: 200 mg
- Light: 400 - 800 mg
- Common: 800 - 1200 mg
- Strong: 1200 - 1600 mg
- Heavy: 1600 mg +

**Duration:**
- Total: 8 - 12 hours
- Onset: 100 - 180 minutes

**S-Adenosyl-L-methionine** (also called **S-Adenosyl methionine** , **Ademethionine** and commonly as **SAMe** and **SAM-e** ) is a common cosubstrate involved in methyl group transfers, transsulfuration, and aminopropylation in biological organisms. SAMe is an amino acid methionine bound to an ATP molecule that circulates in the blood naturally and acts as a 'methyl donor'. A methyl group in chemistry is simply a carbon molecule (bound to some hydrogens), and donating a methyl group to other molecules can accelerate or preserve reactions in the body as a form of metabolic 'maintenance'. [*[citation needed](https://psychonautwiki.org/wiki/Citation_needed)*]

SAM-e is available over the counter and by prescription in the treatment of depression and osteoarthritis. It is generally distributed in enteric-coated tablets, which allows the supplement to pass through the low pH environment of the stomach to the gastrointestinal tract, raising the bioavaliability by 600%.

A review of trials assessing oral doses of SAM-e between 200mg and 1600mg notes that they appear to have similar efficacy to tricyclic antidepressants as well as being more effective than placebo.

## Chemistry

S-adenosyl methionine is an [endogenous](/w/index.php?title=Endogenous&action=edit&redlink=1) molecule, found as a substrate synthesized by the sub-groups adenosine and methionine through an the enzyme methionine adenosyltransferase. The adenosine subcomponent is comprised of an adedine nucleobase bonded to a ribose chain. This ribose chain is attached to the terminal carbon of the methionine group. Methionine is a butyl carboxylic acid substituted at R 2 with an amino group and at R 4 with a methylthio (carbon-sulphur) group. It is an essential methyl donator in metabolic reactions. [*[citation needed](https://psychonautwiki.org/wiki/Citation_needed)*]

## Pharmacology

SAM-e is an [endogenous](/w/index.php?title=Endogenous&action=edit&redlink=1) molecule that has numerous roles including methyl donation in neurotransmitter synthesis, antioxidative effects (radical scavenging, glutathione precursor), anti-inflammatory effects, and neuroprotective effects.

SAM-e, in addition to providing ATP to the cell, also can convert nicotinamine into N-methyl-nicotinamide (NMNA) via nicotinamide N-methyltransferase, NMNA which can prevent choline efflux from the brain and neuron, a process which may account for some of SAM-e's [nootropic](https://psychonautwiki.org/wiki/Nootropic) effects. The involvement of SAM-e in the process of synthesizing serotonin, creatine and dopamine likely play a role in nootropic effects as well.

## Subjective effects

***Disclaimer:** The effects listed below cite the [Subjective Effect Index](https://psychonautwiki.org/wiki/Subjective_effect_index) ( **SEI** ), an open research literature based on anecdotal user reports and the personal analyses of [PsychonautWiki](https://psychonautwiki.org/wiki/PsychonautWiki) [contributors](https://psychonautwiki.org/wiki/Special:TopUsers) . As a result, they should be viewed with a healthy degree of skepticism.*

*It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. *Likewise, **adverse effects** become increasingly likely with higher doses and may include **addiction, severe injury, or death*** ☠.*

In comparison to the effects of other nootropics such as [noopept](https://psychonautwiki.org/wiki/Noopept) , this compound is reported to produce more physical and cognitive stimulation.
### Physical effects
 
- - **[Stimulation](https://psychonautwiki.org/wiki/Stimulation)** - The stimulation which SAM-e presents can be considered as subtle, yet persistent and energetic comparable to that of [caffeine](https://psychonautwiki.org/wiki/Caffeine) , although less forced.
- **[Appetite suppression](https://psychonautwiki.org/wiki/Appetite_suppression)**
- **[Bodily control enhancement](https://psychonautwiki.org/wiki/Bodily_control_enhancement)** - In addition to raising energy levels, SAM-e shows efficacy in improving joint mobility in those with osteoarthritis.
- **[Dehydration](https://psychonautwiki.org/wiki/Dehydration)**
- **[Diarrhea](https://psychonautwiki.org/wiki/Diarrhea)**
- **[Headaches](https://psychonautwiki.org/wiki/Headaches)**
- **[Muscle spasms](https://psychonautwiki.org/wiki/Muscle_spasms)**
- **[Pain relief](https://psychonautwiki.org/wiki/Pain_relief)** - This appears to be about as effective as NSAIDS such as [ibuprofen](/w/index.php?title=Ibuprofen&action=edit&redlink=1) for joint inflammation and pain.
- **[Stamina enhancement](https://psychonautwiki.org/wiki/Stamina_enhancement)**
- **[Stomach cramps](https://psychonautwiki.org/wiki/Stomach_cramps)**
- **[Tactile enhancement](https://psychonautwiki.org/wiki/Tactile_enhancement)** ### Cognitive effects
 
- - **[Analysis enhancement](https://psychonautwiki.org/wiki/Analysis_enhancement)**
- **[Anxiety suppression](https://psychonautwiki.org/wiki/Anxiety_suppression)**
- **[Cognitive euphoria](https://psychonautwiki.org/wiki/Cognitive_euphoria)**
- **[Focus enhancement](https://psychonautwiki.org/wiki/Focus_enhancement)**
- **[Irritability](https://psychonautwiki.org/wiki/Irritability)**
- **[Mania](https://psychonautwiki.org/wiki/Mania)**
- **[Memory enhancement](https://psychonautwiki.org/wiki/Memory_enhancement)**
- **[Mindfulness](https://psychonautwiki.org/wiki/Mindfulness)**
- **[Motivation enhancement](https://psychonautwiki.org/wiki/Motivation_enhancement)**
- **[Rejuvenation](https://psychonautwiki.org/wiki/Rejuvenation)**
- **[Thought connectivity](https://psychonautwiki.org/wiki/Thought_connectivity)**
- **[Thought organization](https://psychonautwiki.org/wiki/Thought_organization)**
- **[Wakefulness](https://psychonautwiki.org/wiki/Wakefulness)**
### Experience reports

There are currently no anecdotal reports which describe the effects of this compound within our [experience index](https://psychonautwiki.org/wiki/Experience_index) . Additional experience reports can be found here:

- [Erowid Experience Vaults: SAMe](https://www.erowid.org/experiences/subs/exp_SAMe.shtml)

## Toxicity and harm potential

There are no clinically significant side-effects of acute SAM-e supplementation. Although side-effects are not commonly reported with SAMe, numerous studies note a small set of participants who experience [mania](https://psychonautwiki.org/wiki/Mania) after supplementing SAM-e. While not common, it appears to be related to SAMe supplementation for unknown reasons; it has been reported in some persons without history of mania as well and does not appear to be related to any pathological condition per se.

SAM-e is also hypothesized to raise homocystine to harmful levels, but this has yet to be proven in a laboratory environment. Still, it is advised to take Sam-e along with folate and B12.

Regardless, it is strongly recommended that one be familiar with [harm reduction practices](https://psychonautwiki.org/wiki/Responsible_drug_use) when using this substance.

### Tolerance and addiction potential

SAM-e is not habit-forming with a low potential for abuse. It does not seem to be capable of causing psychological or physiological dependence among users.

Tolerance to many of the effects of S-adenosyl methionine develops over several weeks of prolonged and repeated use. This results in users having to administer increasingly larger doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption).

## Legal status

- **United States** - SAM-e is approved and legal over the counter for purchase.
- **Germany** - SAM-e is sold as a dietary supplement.
- **Russia** - SAM-e is available by prescription.
- **United Kingdom** - It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.

## See also

- [Responsible use](https://psychonautwiki.org/wiki/Responsible_use)
- [Nootropics](https://psychonautwiki.org/wiki/Nootropics)
- [Noopept](https://psychonautwiki.org/wiki/Noopept)
- [Ashwagandha](/w/index.php?title=Ashwagandha&action=edit&redlink=1)
- [Creatine](https://psychonautwiki.org/wiki/Creatine)

## External links

- [S-Adenosyl methionine (Wikipedia)](https://en.wikipedia.org/wiki/S-Adenosyl_methionine)
- [S-Adenosyl methionine (Examine)](https://examine.com/supplements/s-adenosyl-methionine/)
- [S-Adenosyl methionine (UoMMC)](http://umm.edu/health/medical/altmed/supplement/sadenosylmethionine)

## References
1. ↑ Finkelstein, J. D., Martin, J. J. (April 2000). "Homocysteine".*The International Journal of Biochemistry & Cell Biology*.**32**(4): 385–389.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/s1357-2725(99)00138-7](//doi.org/10.1016%2Fs1357-2725%2899%2900138-7).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[1357-2725](//www.worldcat.org/issn/1357-2725).
2. ↑ Mischoulon, D., Alpert, J. E., Arning, E., Bottiglieri, T., Fava, M., Papakostas, G. I. (June 2012).["Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized Controlled Trial in Major Depressive Disorder"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156851/).*The Journal of clinical psychiatry*.**73**(6): 843–848.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.4088/JCP.11m07139](//doi.org/10.4088%2FJCP.11m07139).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0160-6689](//www.worldcat.org/issn/0160-6689).
3. ↑ Chan, A., Remington, R., Kotyla, E., Lepore, A., Zemianek, J., Shea, T. B. (March 2010). "A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia".*The Journal of Nutrition, Health & Aging*.**14**(3): 224–230.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1007/s12603-010-0054-5](//doi.org/10.1007%2Fs12603-010-0054-5).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[1760-4788](//www.worldcat.org/issn/1760-4788).
4. ↑ 4.0 4.1 Mischoulon, D., Fava, M. (November 2002). "Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence".*The American Journal of Clinical Nutrition*.**76**(5): 1158S–61S.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1093/ajcn/76/5.1158S](//doi.org/10.1093%2Fajcn%2F76%2F5.1158S).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0002-9165](//www.worldcat.org/issn/0002-9165).
5. ↑ Williams, A. C., Ramsden, D. B. (2005). "Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases".*Medical Hypotheses*.**65**(2): 353–362.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/j.mehy.2005.01.042](//doi.org/10.1016%2Fj.mehy.2005.01.042).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0306-9877](//www.worldcat.org/issn/0306-9877).
6. ↑ Witte, S., Lasek, R., Victor, N. (November 2002). "[Meta-analysis of the efficacy of adenosylmethionine and oxaceprol in the treatment of osteoarthritis]".*Der Orthopade*.**31**(11): 1058–1065.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1007/s00132-002-0366-1](//doi.org/10.1007%2Fs00132-002-0366-1).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0085-4530](//www.worldcat.org/issn/0085-4530).
7. ↑ Caruso, I., Pietrogrande, V. (20 November 1987). "Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease".*The American Journal of Medicine*.**83**(5A): 66–71.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1016/0002-9343(87)90854-0](//doi.org/10.1016%2F0002-9343%2887%2990854-0).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0002-9343](//www.worldcat.org/issn/0002-9343).
8. ↑ Berigan, T. R. (2002).["A Case Report of a Manic Episode Triggered by S-Adenosylmethionine (SAMe)"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC315487/).*Primary Care Companion to The Journal of Clinical Psychiatry*.**4**(4): 159.[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[1523-5998](//www.worldcat.org/issn/1523-5998).
9. ↑ Shippy, R. A., Mendez, D., Jones, K., Cergnul, I., Karpiak, S. E. (11 November 2004).["S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535560/).*BMC Psychiatry*.**4**: 38.[doi](http://en.wikipedia.org/wiki/Digital_object_identifier):[10.1186/1471-244X-4-38](//doi.org/10.1186%2F1471-244X-4-38).[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[1471-244X](//www.worldcat.org/issn/1471-244X).
10. ↑ Loehrer, F. M., Schwab, R., Angst, C. P., Haefeli, W. E., Fowler, B. (August 1997). "Influence of oral S-adenosylmethionine on plasma 5-methyltetrahydrofolate, S-adenosylhomocysteine, homocysteine and methionine in healthy humans".*The Journal of Pharmacology and Experimental Therapeutics*.**282**(2): 845–850.[ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number)[0022-3565](//www.worldcat.org/issn/0022-3565).
11. ↑ [Psychoactive Substances Act 2016](https://www.legislation.gov.uk/ukpga/2016/2/contents/enacted)NewPP limit report Cached time: 20251218075806 Cache expiry: 1209600 Dynamic content: false Complications: [] [SMW] In‐text annotation parser time: 0.026 seconds CPU time usage: 0.284 seconds Real time usage: 0.619 seconds Preprocessor visited node count: 1320/1000000 Post‐expand include size: 69857/2097152 bytes Template argument size: 5843/2097152 bytes Highest expansion depth: 12/40 Expensive parser function count: 0/100 Unstrip recursion depth: 0/20 Unstrip post‐expand size: 15755/5000000 bytes Lua time usage: 0.270/7 seconds Lua virtual size: 8.32 MB/50 MB Lua estimated memory usage: 0 bytes ExtLoops count: 11Transclusion expansion time report (%,ms,calls,template) 100.00% 523.281 1 -total 54.41% 284.721 10 Template:Cite_journal 23.13% 121.042 2 Template:Citation_needed 14.10% 73.793 1 Template:Fix 13.16% 68.851 2 Template:Category_handler 9.95% 52.078 1 Template:SubstanceBox/SAM-e 9.31% 48.698 1 Template:SubstanceBox 4.62% 24.197 1 Template:Effects/base 3.96% 20.737 1 Template:Effect_list 3.26% 17.062 2 Template:Effect_column`,
  "wikipedia": `# S-Adenosyl methionine
*Source: https://en.wikipedia.org/wiki/S-Adenosyl_methionine*

S-Adenosyl methionine (SAM), also known under the commercial names of SAMe, SAM-e, or AdoMet, is a common cosubstrate involved in methyl group transfers, transsulfuration, and aminopropylation. Although these anabolic reactions occur throughout the body, most SAM is produced and consumed in the liver. More than 40 methyl transfers from SAM are known, to various substrates such as nucleic acids, proteins, lipids and secondary metabolites. It is made from adenosine triphosphate (ATP) and methionine by methionine adenosyltransferase. SAM was first discovered by Giulio Cantoni in 1952.
In bacteria, SAM is bound by the SAM riboswitch, which regulates genes involved in methionine or cysteine biosynthesis. In eukaryotic cells, SAM serves as a regulator of a variety of processes including DNA, tRNA, and rRNA methylation; immune response; amino acid metabolism; transsulfuration; and more. In plants, SAM is crucial to the biosynthesis of ethylene, an important plant hormone and signaling molecule.
SAMe has been studied for depression, osteoarthritis, and liver diseases with inconclusive results, and while generally considered safe short-term, its long-term safety, use during pregnancy, and risks for people with bipolar disorder or compromised immune systems remain unclear.

## Structure

S-Adenosyl methionine consists of the adenosyl group attached to the sulfur of methionine, providing it with a positive charge. It is synthesized from ATP and methionine by S-Adenosylmethionine synthetase enzyme through the following reaction:

ATP + L-methionine + H2O 
  
    
      
        ⇌
      
    
    {\\displaystyle \\rightleftharpoons }
  
 phosphate + diphosphate + S-adenosyl-L-methionine
The sulfonium functional group present in S-adenosyl methionine is the center of its peculiar reactivity. Depending on the enzyme, S-adenosyl methionine can be converted into one of three  products:

adenosyl radical, which converts to deoxyadenosine (AdO): classic rSAM reaction, also cogenerates methionine
S-adenosyl homocysteine, releasing methyl radical
methylthioadenosine (SMT), homoalanine radical

## Biochemistry

### SAM cycle

The reactions that produce, consume, and regenerate SAM are called the SAM cycle. In the first step of this cycle, the SAM-dependent methylases (EC 2.1.1) that use SAM as a substrate produce S-adenosyl homocysteine as a product. S-Adenosyl homocysteine is a strong negative regulator of nearly all SAM-dependent methylases despite their biological diversity. This is hydrolysed to homocysteine and adenosine by S-adenosylhomocysteine hydrolase EC 3.3.1.1 Archived 2011-06-22 at the Wayback Machine and the homocysteine recycled back to methionine through transfer of a methyl group from 5-methyltetrahydrofolate, by one of the two classes of methionine synthases (i.e. cobalamin-dependent (EC 2.1.1.13 Archived 2011-06-22 at the Wayback Machine) or cobalamin-independent (EC 2.1.1.14 Archived 2011-06-22 at the Wayback Machine)). This methionine can then be converted back to SAM, completing the cycle. In the rate-limiting step of the SAM cycle, MTHFR (methylenetetrahydrofolate reductase) irreversibly reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate.

### Radical SAM enzymes

A large number of enzymes cleave SAM reductively to produce radicals:  5′-deoxyadenosyl 5′-radical, methyl radical, and others.  These enzymes are called radical SAMs.  They all feature iron-sulfur cluster at their active sites. Most enzymes with this capability share a region of sequence homology that includes the motif CxxxCxxC or a close variant. This sequence provides three cysteinyl thiolate ligands that bind to three of the four metals in the 4Fe-4S cluster.  The fourth Fe binds the SAM.
The radical intermediates generated by these enzymes perform a wide variety of unusual chemical reactions. Examples of radical SAM enzymes include spore photoproduct lyase,  activates of pyruvate formate lyase and anaerobic sulfatases, lysine 2,3-aminomutase, and various enzymes of cofactor biosynthesis, peptide modification, metalloprotein cluster formation, tRNA modification, lipid metabolism, etc. Some radical SAM enzymes use a second SAM as a methyl donor. Radical SAM enzymes are much more abundant in anaerobic bacteria than in aerobic organisms. They can be found in all domains of life and are largely unexplored. A recent bioinformatics study concluded that this family of enzymes includes at least 114,000 sequences including 65 unique reactions.
Deficiencies in radical SAM enzymes have been associated with a variety of diseases including congenital heart disease, amyotrophic lateral sclerosis, and increased viral susceptibility.

### Polyamine biosynthesis

Another major role of SAM is in polyamine biosynthesis. Here, SAM is decarboxylated by adenosylmethionine decarboxylase (EC 4.1.1.50 Archived 2011-06-22 at the Wayback Machine) to form S-adenosylmethioninamine. This compound then donates its n-propylamine group in the biosynthesis of polyamines such as spermidine and spermine from putrescine.
SAM is required for cellular growth and repair. It is also involved in the biosynthesis of several hormones and neurotransmitters that affect mood, such as epinephrine.  Methyltransferases are also responsible for the addition of methyl groups to the 2′ hydroxyls of the first and second nucleotides next to the 5′ cap in messenger RNA.

## Therapeutic uses

SAMe has been studied for depression, osteoarthritis, and liver diseases with inconclusive results, and while generally considered safe short-term, its long-term safety, use during pregnancy, and risks for people with bipolar disorder or compromised immune systems remain unclear.

### Osteoarthrtitis pain

As of 2012, the evidence was inconclusive as to whether SAM can mitigate the pain of osteoarthritis; clinical trials that had been conducted were too small from which to generalize.

### Liver disease

The SAM cycle has been closely tied to the liver since 1947 because people with alcoholic cirrhosis of the liver would accumulate large amounts of methionine in their blood. While multiple lines of evidence from laboratory tests on cells and animal models suggest that SAM might be useful to treat various liver diseases, as of 2012 SAM had not been studied in any large randomized placebo-controlled clinical trials that would allow an assessment of its efficacy and safety.

### Depression

A 2016 Cochrane review concluded that for major depressive disorder, "Given the absence of high quality evidence and the inability to draw firm conclusions based on that evidence, the use of SAMe for the treatment of depression in adults should be investigated further."
A 2020 systematic review found that it performed significantly better than placebo, and  had similar outcomes to other commonly used antidepressants (imipramine and escitalopram).

### Anti-cancer treatment

SAM has recently been shown to play a role in epigenetic regulation. DNA methylation is a key regulator in epigenetic modification during mammalian cell development and differentiation. In mouse models, excess levels of SAM have been implicated in erroneous methylation patterns associated with diabetic neuropathy. SAM serves as the methyl donor in cytosine methylation, which is a key epigenetic regulatory process. Because of this impact on epigenetic regulation, SAM has been tested as an anti-cancer treatment. In many cancers, proliferation is dependent on having low levels of DNA methylation. In vitro addition in such cancers has been shown to remethylate oncogene promoter sequences and decrease the production of proto-oncogenes. In cancers such as colorectal cancer, aberrant global hypermethylation can inhibit promoter regions of tumor-suppressing genes. Contrary to the former information, colorectal cancers (CRCs) are characterized by global hypomethylation and promoter-specific DNA methylation.

## Pharmacokinetics

Oral SAM achieves peak plasma concentrations three to five hours after ingestion of an enteric-coated tablet (400–1000 mg). The half-life is about 100 minutes.

## Availability in different countries

In Canada, the UK, and the United States, SAM is sold as a dietary supplement under the marketing name SAM-e (also spelled SAME or SAMe). It was introduced in the US in 1999, after the Dietary Supplement Health and Education Act was passed in 1994.
It was introduced as a prescription drug in Italy in 1979, in Spain in 1985, and in Germany in 1989. As of 2012, it was sold as a prescription drug in Russia, India, China, Italy, Germany, Vietnam, and Mexico.

## Adverse effects

Gastrointestinal disorder, dyspepsia and anxiety can occur with SAM consumption. Long-term effects are unknown. SAM is a weak DNA-alkylating agent.
Another reported side effect of SAM is insomnia; therefore, the supplement is often taken in the morning. Other reports of mild side effects include lack of appetite, constipation, nausea, dry mouth, sweating, and anxiety/nervousness, but in placebo-controlled studies, these side effects occur at about the same incidence in the placebo groups.

### Interactions and contraindications

Taking SAM at the same time as some drugs may increase the risk of serotonin syndrome, a potentially dangerous condition caused by having too much serotonin. These drugs include, but are certainly not limited to, dextromethorphan (Robitussin), meperidine (Demerol), pentazocine (Talwin), and tramadol (Ultram).
SAM can also interact with many antidepressant medications — including tryptophan and the herbal medicine Hypericum perforatum (St. John's wort) — increasing the potential for serotonin syndrome or other side effects, and may reduce the effectiveness of levodopa for Parkinson's disease. SAM can increase the risk of manic episodes in people who have bipolar disorder.

### Toxicity

A 2022 study concluded that SAMe could be toxic. Jean-Michel Fustin of Manchester University said that the researchers found that excess SAMe breaks down into adenine and methylthioadenosine in the body, both producing the paradoxical effect of inhibiting methylation. This was found in laboratory mice, causing harm to health, and in in vitro tests on human cells.
`,
};
